|Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.|
|PMID: 22039239 Owner: NLM Status: MEDLINE|
|PURPOSE: Carcinoembryonic antigen cell adhesion molecule (CEACAM)-1 is a multi-functional protein, with strong predictive value for poor prognosis when found in primary cutaneous melanoma lesions. In this study, the expression of CEACAM1 in uveal melanoma was correlated with clinicopathologic parameters.
METHODS: CEACAM1 expression was immunohistochemically evaluated in 79 primary uveal melanomas and 21 liver metastases of patients who were treated at the Hadassah-Hebrew University Medical Center between the years 1986 and 2006. The findings were correlated with location, cell type, extracellular matrix patterns, tumor size, and metastatic disease.
RESULTS: CEACAM1 was expressed in 45% of the primary tumors compared with 81% of the metastases (Fisher's exact test, P = 0.003). There was no significant association between CEACAM1 and location of the primary tumors. Histologically, CEACAM1 was associated with epithelioid-type tumors (69.6%), but not with spindle-type tumors (25.0%) (Cramer's V = 0.354; P = 0.019). Also it was significantly associated with network extracellular matrix pattern (73.3%), but not with silent pattern (11.8%) (Cramer's V = 0.510; P = 0.004). CEACAM1-positive tumors were not statistically different in size from CEACAM1-negative tumors. The higher frequency of CEACAM1 in patients who ultimately developed metastases (58.8% vs. 41.7%) was not statistically significant (likelihood ratio χ(2) = 2.069; P = 0.1503).
CONCLUSIONS: This report describes CEACAM1 expression in uveal melanoma. Correlation with poor prognostic factors such as epithelioid cell type and networks of extracellular matrix pattern was found, but definitive prognostic conclusions still cannot be deduced. Additional validation studies on the use of CEACAM1 expression as a prognostic marker are warranted.
|Nur Khatib; Jacob Pe'er; Rona Ortenberg; Jacob Schachter; Shahar Frenkel; Gal Markel; Radgonde Amer|
Related Documents :
|8548759 - Association of loss of heterozygosity on chromosome 17p with high platelet-derived grow...
16247479 - Overexpression of cebpbeta correlates with decreased tff1 in gastric cancer.
9076469 - Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy w...
9331099 - Mapping of dna amplifications at 15 chromosomal localizations in 1875 breast tumors: de...
21113499 - Nuclear ploidy is an indicator of malignancy endocrine pancreatic tumor.
15610859 - Detection of c-erb b2 gene amplification in bilharzial associated bladder cancer using ...
24762069 - Intestinal microbiota: unexpected alliance with tumor therapy.
19664879 - Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase...
19794949 - Management of dermoid tumor in the medial canthal area.
|Type: Comparative Study; Journal Article Date: 2011-12-09|
|Title: Investigative ophthalmology & visual science Volume: 52 ISSN: 1552-5783 ISO Abbreviation: Invest. Ophthalmol. Vis. Sci. Publication Date: 2011|
|Created Date: 2011-12-14 Completed Date: 2012-01-31 Revised Date: 2013-01-09|
Medline Journal Info:
|Nlm Unique ID: 7703701 Medline TA: Invest Ophthalmol Vis Sci Country: United States|
|Languages: eng Pagination: 9368-72 Citation Subset: IM|
|Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.|
|APA/MLA Format Download EndNote Download BibTex|
Aged, 80 and over
Antibodies, Monoclonal / immunology
Antigens, CD / biosynthesis*
Cell Adhesion Molecules / biosynthesis*
Israel / epidemiology
Melanoma / metabolism*, mortality, pathology
Repressor Proteins / immunology, metabolism
Survival Rate / trends
Trans-Activators / immunology, metabolism
Tumor Cells, Cultured
Tumor Markers, Biological / metabolism
Uveal Neoplasms / metabolism*, mortality, pathology
|0/Antibodies, Monoclonal; 0/Antigens, CD; 0/CD66 antigens; 0/CITED2 protein, human; 0/Cell Adhesion Molecules; 0/Repressor Proteins; 0/Trans-Activators; 0/Tumor Markers, Biological|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Central retinal function as measured by the multifocal electroretinogram and flicker perimetry in ea...
Next Document: eNOS, a pressure-dependent regulator of intraocular pressure.